FDA seeks math of similarity

Share this article:

The FDA is looking for mathletes, of a sort. Regulatory Focus reports that the FDA is looking to create a mathematical model that will help regulators assess the sameness of generics and maybe even biosimilars.

RF says the Center for Drug Evaluation and Research will oversee the three-year project which will cost around $1 million.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Channel

 

Did you miss January's Top 40 Healthcare Transformers issue? Read how these inventors, strategists, entrepreneurs and wonks are challenging, disrupting and otherwise transforming the healthcare business. And join us April 30 to honor them at the Transforming Healthcare Dinner. Click here.